In osteoarthritis (OA), miR-411 was repressed by IL-1β treatment in OA cartilage, directly targeted MMP-13 to inhibit chondrocyte cell proliferation, and increased expression of type II and type IV collagen [42]. Here, SGCG is linked to osteoarthritis.